Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)

NCT02024230 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Atrial Fibrillation
Stroke
Fetal Blood Loss
Major Bleeding
All Cause Mortality

Interventions

DRUG: Rivaroxaban or Warfarin

Sponsor

Fujita Health University